1. Home
  2. EXAS vs CUBE Comparison

EXAS vs CUBE Comparison

Compare EXAS & CUBE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EXAS
  • CUBE
  • Stock Information
  • Founded
  • EXAS 1995
  • CUBE 2004
  • Country
  • EXAS United States
  • CUBE United States
  • Employees
  • EXAS N/A
  • CUBE N/A
  • Industry
  • EXAS Medical Specialities
  • CUBE Real Estate Investment Trusts
  • Sector
  • EXAS Health Care
  • CUBE Real Estate
  • Exchange
  • EXAS Nasdaq
  • CUBE Nasdaq
  • Market Cap
  • EXAS 12.3B
  • CUBE 11.3B
  • IPO Year
  • EXAS N/A
  • CUBE 2004
  • Fundamental
  • Price
  • EXAS $49.33
  • CUBE $48.33
  • Analyst Decision
  • EXAS Strong Buy
  • CUBE Hold
  • Analyst Count
  • EXAS 17
  • CUBE 11
  • Target Price
  • EXAS $73.07
  • CUBE $51.45
  • AVG Volume (30 Days)
  • EXAS 3.3M
  • CUBE 1.4M
  • Earning Date
  • EXAS 11-05-2024
  • CUBE 10-31-2024
  • Dividend Yield
  • EXAS N/A
  • CUBE 4.22%
  • EPS Growth
  • EXAS N/A
  • CUBE 5.93
  • EPS
  • EXAS N/A
  • CUBE 1.78
  • Revenue
  • EXAS $2,692,328,000.00
  • CUBE $1,066,921,000.00
  • Revenue This Year
  • EXAS $12.41
  • CUBE N/A
  • Revenue Next Year
  • EXAS $11.64
  • CUBE $3.36
  • P/E Ratio
  • EXAS N/A
  • CUBE $27.15
  • Revenue Growth
  • EXAS 11.91
  • CUBE 1.56
  • 52 Week Low
  • EXAS $40.62
  • CUBE $38.29
  • 52 Week High
  • EXAS $79.62
  • CUBE $55.14
  • Technical
  • Relative Strength Index (RSI)
  • EXAS 22.62
  • CUBE 46.88
  • Support Level
  • EXAS $48.02
  • CUBE $47.78
  • Resistance Level
  • EXAS $52.32
  • CUBE $48.95
  • Average True Range (ATR)
  • EXAS 2.86
  • CUBE 1.22
  • MACD
  • EXAS -1.89
  • CUBE 0.16
  • Stochastic Oscillator
  • EXAS 5.28
  • CUBE 69.19

About EXAS Exact Sciences Corporation

Exact Sciences Corporation, headquartered in Madison, Wisconsin, provides cancer screening and diagnostic test products in the United States and internationally. Exact's Cologuard screening test, a noninvasive stool-based DNA test, is a pre-cancer screening test for colorectal cancer. The company also competes in the precision oncology market with Oncotype DX, a suite of tissue-based genomic tests for estimating recurrence risk and likelihood of benefit from chemotherapy for breast and colon cancer, and OncoExTra, a liquid-based comprehensive genomic profiling test. It is also developing liquid biopsy tests for molecular residual disease, or MRD, colorectal cancer screening, and multicancer screening.

About CUBE CubeSmart

CubeSmart is a real estate investment trust that acquires, owns, and manages self-storage facilities throughout the United States. The company's real estate portfolio is composed of buildings with numerous enclosed storage areas for both residential and commercial customers to rent mainly on a month-by-month basis. Most of CubeSmart's facilities are located in Florida, Texas, California, New York, and Illinois. Cumulatively, these states account for both the majority of the square footage in the company's real estate portfolio and the majority of its revenue. The company derives nearly all of its revenue from rental income from tenants utilizing its storage facilities.

Share on Social Networks: